Article info
PDFSection 5: Patient Safety and Quality Assurance
5PSQ-067 Detection of adverse neuropsychiatric reactions associated with abiraterone and enzalutamide treatments in the hospital
Citation
5PSQ-067 Detection of adverse neuropsychiatric reactions associated with abiraterone and enzalutamide treatments in the hospital
Publication history
- First published March 11, 2019.
Online issue publication
May 12, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions